Inducing Compliance with Postmarket Studies for Drugs Under FDA's Accelerated Approval Pathway. - Liang (Leon) Xu; Hui Zhao 021; Nicholas C. Petruzzi (Manuf. Serv. Oper. Manag., 2021)

Inventory Sharing and Demand-Side Underweighting. - Hui Zhao 021; Liang (Leon) Xu; Enno Siemsen (Manuf. Serv. Oper. Manag., 2021)

Outcome-Based Reimbursement: The Solution to High Drug Spending? - Liang (Leon) Xu; Hongmin Li 004; Hui Zhao 021 (Manuf. Serv. Oper. Manag., 2022)